Skip to main content

Peer Review reports

From: Second-line chemotherapy after early disease progression during first-line chemotherapy containing bevacizumab for patients with metastatic colorectal cancer

Original Submission
7 Apr 2021 Submitted Original manuscript
30 May 2021 Reviewed Reviewer Report
22 Jun 2021 Reviewed Reviewer Report
26 Jul 2021 Author responded Author comments - shun yamamoto
Resubmission - Version 2
26 Jul 2021 Submitted Manuscript version 2
30 Aug 2021 Reviewed Reviewer Report
20 Sep 2021 Reviewed Reviewer Report
24 Sep 2021 Author responded Author comments - shun yamamoto
Resubmission - Version 3
24 Sep 2021 Submitted Manuscript version 3
13 Oct 2021 Reviewed Reviewer Report
13 Oct 2021 Reviewed Reviewer Report
14 Oct 2021 Author responded Author comments - shun yamamoto
Resubmission - Version 4
14 Oct 2021 Submitted Manuscript version 4
Publishing
19 Oct 2021 Editorially accepted
29 Oct 2021 Article published 10.1186/s12885-021-08890-6

You can find further information about peer review here.

Back to article page